| Bid Price | 8.00p | High Price | 9.30p |
|---|
| Ask Price | 9.50p | Low Price | 8.00p |
|---|
| Open Price | 8.75p | Spread | 15.79% |
|---|
| Prev Close | 8.75p | Volume | 9,349 |
|---|
Crism Therapeutics Corporation Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Dec 16, 2025 | 8.75 | 9.30 | 8.00 | 8.75 | 9,349 |
| Dec 15, 2025 | 8.75 | 9.05 | 8.30 | 8.75 | 101,013 |
| Dec 12, 2025 | 8.75 | 9.10 | 8.25 | 8.75 | 53,429 |
| Dec 11, 2025 | 8.75 | 9.30 | 8.00 | 8.75 | 97,555 |
| Dec 10, 2025 | 9.50 | 9.85 | 8.22 | 8.75 | 331,949 |
Crism Therapeutics Corporation Information
| Name | Crism Therapeutics Corporation | Index | FTSE AIM All Share |
|---|
| ISIN | VGG042401262 | Epic | CRTX |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 15,000 | Trading Status | Closed |
|---|
| Shares in Issue | 51.07 m | Prev Close | 8.75p |
|---|
| PE Ratio | 0.02858 | Market Cap | £4.47 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.03 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.667864 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 3.647059 | Quick Ratio | 3.647059 |
|---|
Crism Therapeutics Corporation Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 15/12/25 | PLAC | Gerald Beaney | NED | 111,111 @ £0.09 | £10,000.00 |
| 15/12/25 | PLAC | Andrew Webb | CEO | 916,667 @ £0.09 | £82,500.00 |
| 15/12/25 | PLAC | Christopher McConville | ED | 83,333 @ £0.09 | £7,500.00 |
| 03/07/25 | PLAC | Gerald Beaney | NED | 112,500 @ £0.12 | £13,500.00 |
| 03/07/25 | PLAC | Andrew Webb | CEO | 291,667 @ £0.12 | £35,000.00 |
| 07/04/25 | BUY | Gerald Beaney | NED | 20,182 @ £0.10 | £1,994.00 |
| 03/06/24 | BUY | Gerald Beaney | NED | 25,000 @ £0.09 | £2,316.00 |
Crism Therapeutics Corporation News
